Sopharma AD (WSE: SPH)

Market Cap	2.12B
Revenue (ttm)	4.35B
Net Income (ttm)	170.91M
Shares Out	n/a
EPS (ttm)	1.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Nov 7, 2024

Volume	27
Open	13.05
Previous Close	13.00
Day's Range	13.05 - 13.05
52-Week Range	11.40 - 16.60
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 30, 2025

About Sopharma AD

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. The company operates through Production of Pharmaceutical Products; Distribution of Pharmaceutical Products (Goods); and Others. It offers Carsil to treat liver disease; Tempalgin and Analgin, a painkiller; Tabex, drug used for smoking secession; Tribestan, drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin, used for diseases of the peripheral nervous system; Methylpredni...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1933
• Employees: 4,721
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SPH

Financial Performance

In 2023, Sopharma AD's revenue was 1.89 billion, an increase of 12.95% compared to the previous year's 1.67 billion. Earnings were 95.21 million, an increase of 33.87%.

Financial numbers in BGN